Dr. Jeffrey Flier is an endocrinologist and a professor at Harvard Medical School, where he was the dean from 2007 to 2016.

Hims & Hers Health (HIMS) is trying its best to stay relevant in the multi-billion dollar obesity treatment market. Despite a ...

Carrington College has named Nick Gomez as its new president, with a focus on expanding the college's footprint in Sacramento ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide.

The Zacks Medical Info Systems industry, to which Hims & Hers Health belongs, has lost 5.8% over this period. Now the key question is: Where could the stock be headed in the near term? While media ...

Telehealth providers like Hims and Ro say they are helping fill ... often after simply filling out a questionnaire about their medical history, medications and treatment goals.

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health ...

Introduction: What Even Is Hims & Hers Health ... physicians, and other medical governing bodies, and that body of medicine is prescribed to patients who have a series of issues that commonly ...

I like how HIMS is combining a data-intense AI-assisted platform that can make a tech bro smile with sound practices based on respect for and working with human medical professionals. It’ll take ...

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.